Cargando…

p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression.

Immunohistochemically detectable p53 protein using a polyclonal antibody (CM-1) was studied in 42 carcinomas of which 11 were grade I, 22 grade II and nine grade III carcinomas. Additionally 14 urothelial dysplasias were studied. In 11 of these a diagnosis of transitional cell carcinoma was establis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soini, Y., Turpeenniemi-Hujanen, T., Kamel, D., Autio-Harmainen, H., Risteli, J., Risteli, L., Nuorva, K., Pääkkö, P., Vähäkangas, K.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968713/ https://www.ncbi.nlm.nih.gov/pubmed/8217593

Ejemplares similares

p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations
por: Peltonen, Jenni K, et al.
Publicado: (2010)

Apoptotic activity is increased in parallel with the metaplasia–dysplasia–carcinoma sequence of the bronchial epithelium
por: Törmänen, U, et al.
Publicado: (1999)

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study
por: Peltonen, Jenni K, et al.
Publicado: (2011)

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
por: Talvensaari-Mattila, A, et al.
Publicado: (2003)

Snail promotes an invasive phenotype in lung carcinoma
por: Merikallio, Heta, et al.
Publicado: (2012)

Variability in the precursor proteins of collagen I and III in different stages of COPD
por: Harju, Terttu, et al.
Publicado: (2010)

Demonstration of increased collagen synthesis in irradiated human skin in vivo.
por: Autio, P., et al.
Publicado: (1998)

p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder.
por: Serth, J., et al.
Publicado: (1995)

Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo
por: Kauppila, S, et al.
Publicado: (1999)

Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients.
por: Saarto, T., et al.
Publicado: (1998)

Urinary Bladder Xanthoma – Is Immunohistochemistry Necessary?
por: Raghavendran, M., et al.
Publicado: (2016)

Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
por: Elomaa, I., et al.
Publicado: (1992)

Combination of Strong MMP-2 and Weak TIMP-2 Immunostainings Is a Significant Prognostic Factor in Endometrial Carcinoma
por: Honkavuori-Toivola, Maria, et al.
Publicado: (2013)

The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia
por: Januszewicz, Wladyslaw, et al.
Publicado: (2022)

Type III collagen metabolism in soft tissue sarcomas.
por: Wiklund, T. A., et al.
Publicado: (1992)

Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.
por: Kylmälä, T., et al.
Publicado: (1995)

Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.
por: Blomqvist, C., et al.
Publicado: (1996)

Type I and type III collagen metabolites in adult osteosarcoma patients.
por: Wiklund, T., et al.
Publicado: (1996)

Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptides
por: Turunen, Sanna, et al.
Publicado: (2015)

Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer.
por: KylmÃ¤lÃ¤, T., et al.
Publicado: (1997)

Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma
por: Anne, Talvensaari-Mattila, et al.
Publicado: (2010)

Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP
por: Peroja, Pekka, et al.
Publicado: (2018)

Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer.
por: Santala, M., et al.
Publicado: (1998)

Serum PINP, PIIINP, galectin-3, and ST2 as surrogates of myocardial fibrosis and echocardiographic left venticular diastolic filling properties
por: Lepojärvi, E. Samuli, et al.
Publicado: (2015)

The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients
por: Paula, Kuvaja, et al.
Publicado: (2007)

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry
por: Wirtz, Ralph M., et al.
Publicado: (2016)

p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001)

Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion
por: Vakkala, M, et al.
Publicado: (1999)

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients
por: Tokola, Susanna, et al.
Publicado: (2020)

Interim and end‐of‐treatment PET‐CT suffers from high false‐positive rates in DLBCL: Biopsy is needed prior to treatment decisions
por: Tokola, Susanna, et al.
Publicado: (2021)

Atrial extracellular matrix remodelling in patients with atrial fibrillation
por: Polyakova, V, et al.
Publicado: (2008)

Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma
por: Peroja, Pekka, et al.
Publicado: (2012)

Sessile serrated adenomas with dysplasia: morphological patterns and correlations with MLH1 immunohistochemistry
por: Liu, Cheng, et al.
Publicado: (2017)

Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers
por: Kantola, T, et al.
Publicado: (2014)

Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma
por: Kahlos, K, et al.
Publicado: (2000)

G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder
por: Niehans, G A, et al.
Publicado: (1999)

Type 1 and 3 collagen production by bone marrow mesenchymal stromal cells is suppressed in vitro after exposure to sepsis patient serum
por: Pernu, R, et al.
Publicado: (2015)

Prognostic value of dysadherin in cancer: A systematic review and meta-analysis
por: Niinivirta, Aino, et al.
Publicado: (2022)

Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival.
por: Soini, Y., et al.
Publicado: (1996)

The Potential Value of EGFR and P53 Immunostaining in Tumors of the Urinary Bladder
por: Ibrahim, N, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_i4889g3had0ekjef47jvnoueo1